[1]郑双云*,韦瑞红,陈凤英,等.妊娠期肝内胆汁淤积症行茵栀黄、熊去氧胆酸及腺苷蛋氨酸联合治疗的临床效果观察[J].中国计划生育和妇产科,2019,(4):41-44.
 ZHENG Shuang-yun*,WEI Rui-hong,CHEN Feng-ying,et al.Clinical efficacy of the Yinzhihuang, ursodeoxycholic acid and adenosylmethionine mattel combination therapy in the treatment of intrahepatic cholestasis of pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2019,(4):41-44.
点击复制

妊娠期肝内胆汁淤积症行茵栀黄、熊去氧胆酸及腺苷蛋氨酸联合治疗的临床效果观察
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年4期
页码:
41-44
栏目:
论著与临床
出版日期:
2019-04-25

文章信息/Info

Title:
Clinical efficacy of the Yinzhihuang, ursodeoxycholic acid and adenosylmethionine mattel combination therapy in the treatment of intrahepatic cholestasis of pregnancy
作者:
郑双云*韦瑞红陈凤英王冰
中山大学附属第八医院妇产科
Author(s):
ZHENG Shuang-yun* WEI Rui-hong CHEN Feng-ying WANG Bing
Department of Obstetrics and Gynecology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen Guangdong 518000,P.R.China
关键词:
妊娠期肝内胆汁淤积症茵栀黄熊去氧胆酸腺苷蛋氨酸临床效果
Keywords:
intrahepatic cholestasis of pregnancy Yinzhihuang ursodeoxycholic acid adenosylmethionine clinical effect
分类号:
R 714.256
摘要:
目的探讨妊娠期肝内胆汁淤积症行茵栀黄、熊去氧胆酸以及腺苷蛋氨酸联合治疗的临床效果。方法选取2013~2016年中山大学附属第八医院收治的妊娠期肝内胆汁淤积症患者90例,依据随机数字表法分为对照组和观察组,各45例。对照组行腺苷蛋氨酸联合熊去氧胆酸治疗,观察组在对照组基础上加用茵栀黄联合治疗。比较两组患者治疗有效率、生化指标及妊娠结局。结果观察组治疗总有效率9556 %,高于对照组8222 %(P<005)。治疗前两组患者总胆汁酸、谷丙转氨酶、谷草转氨酶、总胆红素等生化指标比较差异无统计学意义(P>0
Abstract:
ObjectiveTo explore clinical efficacy of the Yinzhihuang, ursodeoxycholic acid and adenosylmethionine mattel combination therapy in the treatment of intrahepatic cholestasis of pregnancy.Methods90 patients with intrahepatic cholestasis of pregnancy who w

参考文献/References:

[1]蔡艾杞,刘路遥,张应凤,等.妊娠期肝内胆汁淤积症的研究进展 [J].现代妇产科进展,2016,25(11):871-873. [2]曹杰,蔡艾杞,田立碧,等.熊去氧胆酸、腺苷蛋氨酸联合多烯磷脂酰胆碱对妊娠期肝内胆汁淤积症患者相关指标的影响[J].中国药房,2017,28(18):2509-2511. [3]KONG Xiang, KONG Yan, ZHANG Fangyuan, et al. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study)[J]. Medicine, 2016, 95(40): e 4949. [4]贺晶,杨慧霞,段涛,等.妊娠期肝内胆汁淤积症诊疗指南(2015) [J].临床肝胆病杂志,2015,31(10):1575-1578. [5]Kawakita T, Parikh L, Reddy U, et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy[J]. Am J Obstet Gynecol, 2015, 212(1, S): S 295. [6]文香,胡章雪,廖莉.妊娠期肝内胆汁淤积症血清总胆汁酸与新生儿肺损伤程度的相关性[J].重庆医学,2017,46(19):2621-2623. [7]Samji NS, Kanth R, Roy P. Ursodeyxucholic acid in intrahepatic cholestasis of pregnancy: An updated meta-analysis and systematic review[J]. Gastroenterology, 2017, 152(5, 1): S1079-S1080. [8]ZHANG Yang, LU Linlin, Victor DW, et al. Ursodeoxycholic acid and s-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy: a meta-analysis [J]. Hepat Mon, 2016, 16(8): e 38558. [9]Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy [J]. Clin Liver Dis, 2016, 20(1): 177-189. [10]YANG Hong-ying, XU Xiao-qing, ZHU Jun-xi, et al. Clinical analysis of ursodeoxycholic acid combined with adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy[J]. Chongqing Medicine, 2016, 45(20): 2845-2847. [11]CAO J, CAI A, TIAN L, et al. Effects of ursodeoxycholic acid and adenosine methionine combined with polyene phosphatidylcholine on related indicators of pregnancy with intrahepatic cholestasis[J]. China Pharmacy, 2017, 2(18): 2518-2520. [12]WANG Xin-yan, QIU Ming-juan, LU Ting, et al. Yinzhihuang oral liquid combined with ursodeoxycholic acid and mattel treatment of intrahepatic cholestasis of pregnancy on the treatment[J]. Journal of Nanjing University of Chinese Medicine, 2016, 32(6): 595-597.

相似文献/References:

[1]侯卫萍.妊娠期肝内胆汁淤积症的围产儿结局探讨[J].中国计划生育和妇产科,2012,(03):0.
 HOU Wei - Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(4):0.
[2]徐洲,王晓银,肖兵,等.妊娠期肝内胆汁淤积症分娩时机及方式探讨[J].中国计划生育和妇产科,2014,(04):0.
 XU Zhou,WANG Xiao-yin,XIAO Bing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[3]李萍,陈红,赵虎,等.妊娠期肝内胆汁淤积症患者的分娩方式探讨[J].中国计划生育和妇产科,2014,(05):0.
 LI Ping,CHEN Hong,ZHAO Hu,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[4]邵勇.妊娠期肝内胆汁淤积症转诊常见问题及注意事项[J].中国计划生育和妇产科,2018,(3):1.
[5]潘玥*,李娥琼.不同孕周妊娠期肝内胆汁淤积症生化指标差异与围产儿预后的分析[J].中国计划生育和妇产科,2019,(1):53.
 PAN Yue*,LI E-qiong.Analysis of biochemical markers of intrahepatic cholestasis of pregnancy in different gestational weeks and prognosis of perinatal infants[J].Chinese Journal of Family Planning & Gynecotokology,2019,(4):53.
[6]肖俊,张宇骄,傅晓冬*.熊去氧胆酸联合茵陈制剂治疗妊娠期肝内胆汁淤积症的有效性及母婴结局的Meta分析[J].中国计划生育和妇产科,2019,(5):81.
 XIAO Jun,ZHANG Yu-jiao,FU Xiao-dong*.A meta-analysis of the efficiency and the maternal and infant outcome by applying ursodeoxycholic acid associate with Yinchen decoction in treatment of intrahepatic cholestasis of pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2019,(4):81.

更新日期/Last Update: 2019-04-25